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Abstract
Background: Cocaine increases the level of endogenous dopamine (DA) in the striatum by blocking the DA transporter.
Endogenous DA modulates glutamatergic inputs to striatal neurons and this modulation influences motor activity. Since D2
DA and A2A-adenosine receptors (A2A-Rs) have antagonistic effects on striatal neurons, drugs targeting adenosine
receptors such as caffeine-like compounds, could enhance psychomotor stimulant effects of cocaine. In this study, we
analyzed the electrophysiological effects of cocaine and A2A-Rs antagonists in striatal slices and the motor effects produced
by this pharmacological modulation in rodents.
Principal Findings: Concomitant administration of cocaine and A2A-Rs antagonists reduced glutamatergic synaptic
transmission in striatal spiny neurons while these drugs failed to produce this effect when given in isolation. This inhibitory
effect was dependent on the activation of D2-like receptors and the release of endocannabinoids since it was prevented by
L-sulpiride and reduced by a CB1 receptor antagonist. Combined application of cocaine and A2A-R antagonists also reduced
the firing frequency of striatal cholinergic interneurons suggesting that changes in cholinergic tone might contribute to this
synaptic modulation. Finally, A2A-Rs antagonists, in the presence of a sub-threshold dose of cocaine, enhanced locomotion
and, in line with the electrophysiological experiments, this enhanced activity required activation of D2-like and CB1
receptors.
Conclusions: The present study provides a possible synaptic mechanism explaining how caffeine-like compounds could
enhance psychomotor stimulant effects of cocaine.
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Introduction
Cocaine dependence is difficult to treat also because it is often
associated with the abuse of other psychoactive compounds [1]. It
causes hyperactivity and locomotor sensitization [2–4]. Cocaine
blocks the dopamine (DA) transporter (DAT), decreases DA
reuptake increasing extracellular DA levels in different brain
regions, including the striatum [5–13]. This effect of cocaine alters
glutamatergic striatal synaptic transmission [14] and affects motor
function [15,16].
Cocaine self-administration raise even more concerns when
relevant doses of other commonly assumed psychoactive com-
pounds, such as caffeine-containing beverages, are used together
with this drug. In fact, caffeine is a well-known psychoactive drug
displaying multiple effects on the central nervous system and
specifically antagonizing adenosine receptors [17,18]. The psy-
chomotor stimulant effect of caffeine and its interaction with
endogenous DA [19,20] might play a significant role in the motor
abnormalities induced by cocaine via blockade of adenosine A2A
receptors located on striatal medium spiny neurons (MSNs) [18].
Although A2A-Rs have been classically located on D2-Rs
expressing striato-pallidal projecting neurons [21–23], we have
recently demonstrated that D2 and A2A-Rs are also co-expressed
in striatal large aspiny (LA) cholinergic interneurons [24].
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modulation of firing activity of these cholinergic interneurons
might, in turn, influence the excitatory synaptic transmission in
MSNs of both the direct and indirect pathways via the retrograde
release of endocannabinoids (eCBs). Accordingly, the endocanna-
binoid system finely interacts with striatal glutamatergic and
dopaminergic transmission [24–28].
Thus, the aim of the present study is to characterize the
synaptic interaction between cocaine and A2A-R antagonists in
distinct striatal neuronal subtypes and to explore the possibility
that this interaction influences motor activity providing a possible
model to explain how the concomitant use of caffeine-containing
beverages exacerbates behavioral and motor alterations induced
by cocaine.
Results
Cocaine and A2A Adenosine Receptors Antagonists
Reduce Excitatory Striatal Synaptic Transmission
Sharp electrodes and whole-cell patch-clamp recordings were
obtained from electrophysiologically identified MSNs from dorsal
striata [29,30]. Stimulations of glutamatergic afferents, in the
presence of the GABAA-R antagonist BMI (10 mM), evoked
EPSPs and EPSCs during intracellular and patch-clamp record-
ings, respectively (Figure 1). A stable response was recorded for
10–15 min and subsequently cocaine (10 mM), or A2A-R
antagonists ZM241385 (ZM, 1 mM) or 8-(3-Chlorostyryl)-caffeine
(CSC, 10 mM) were bath-applied in isolation. These drugs did
not affect per se the amplitude of the postsynaptic response, on
the contrary, the co-application of 10 mM cocaine plus
1 mM ZM or plus 10 mM CSC, significantly reduced the EPSPs
and/or EPSCs amplitudes in respect to the baseline
(Figure 1A,B,D). In fact, in the presence of cocaine plus ZM
the EPSP amplitude was reduced by 34.364.5%, (n=6,
P,0.001, Figure 1A), and the EPSC by 36.766.8% (n=6,
P,0.001, Figure 1B), whereas in the presence of cocaine plus
CSC, the EPSC amplitude was reduced by 55.169.3%, (n=5,
Figure 1D). The effect of cocaine in the presence of A2A-R
blockade was dose-dependent (n=4 for each dose, P,0.001;
Figure 1C). Cocaine and ZM, applied in the presence of the D2
receptor antagonist L-sulpiride (5 mM), failed to reduce the EPSP
amplitude (n=4, P.0.05, Figure 1A and dose-response curve,
n=4 for each dose, P.0.05, Figure 1C). Furthermore, 15 min
application of L-sulpiride almost completely reverted the synaptic
inhibition caused by 20 min of cocaine and CSC co-application
(n=5, Figure 1D). These experiments confirmed the pivotal role
of the D2 DA receptor in the D2/A2A interaction exerted by
cocaine and A2A-Rs antagonists.
Cocaine and A2A-R Dependent Reduction of Striatal
Synaptic Transmission is Mediated by Postsynaptic
Intracellular Calcium and Involves Presynaptic
Cannabinoid Receptor 1 Activation
Striatal short-term modulation of excitatory synaptic trans-
mission in the striatum is a response that can be modulated by the
retrograde action of endogenous cannabinoids [24,31]. In order to
test whether the inhibition of excitatory synaptic transmission
mediated by cocaine co-administered with A2A-R antagonists is
mediated by eCBs, we co-applied cocaine and ZM in the presence
of the CB1-R antagonist AM251 (3 mM). In this conditions the
inhibition of the EPSC amplitude was in fact reduced only by
1463.0% (n=6, P,0.001, Figure 1B) and this effect was observed
at various concentrations of cocaine (P,0.05, Figure 1C).
Furthermore, in a subset of experiments, we patch-clamped
a group of MSNs including BAPTA into the recording pipette, in
order to buffer intracellular calcium levels. Under this condition,
the co-application of 10 mM cocaine plus 10 mM CSC did not
produce any change in the EPSC amplitude (n=6; Figure 1E)
confirming the pivotal role of intracellular calcium levels in the
CB1-R-mediated effects of cocaine and A2A-R antagonist co-
administration.
In previous studies we found that paired-pulse facilitation of the
synaptic response in MSNs during the co-application of a D2-DA
receptor agonist and A2A-R antagonists suggests the involvement
of a presynaptic mechanism in the reduction of the excitatory
transmission since this parameter was increased [24,32]. There-
fore, we tested the effect of combined cocaine and A2A-R
antagonist on EPSCs evoked by paired stimuli (50 ms interval),
assuming that cocaine indirectly facilitates D2-R stimulation by
enhancing endogenous DA levels. Paired-pulse ratio (PPR) values
in the presence of 10 mM cocaine plus the A2A-R antagonists ZM
(n=3) or CSC (n=3) were significantly increased compared to
control conditions (P,0.05; Figure 1F) confirming that cocaine, in
combination to A2A-R antagonism, inhibits glutamatergic synap-
tic transmission by a presynaptic mechanism of action.
Cocaine and A2A-R Antagonist Interaction on Excitatory
Synaptic Transmission in D1-and D2-Receptor Expressing
Striatal MSNs
The classical model of basal ganglia functioning suggests that
the ability of DA to modulate motor control is due to the
segregation of D1 and D2 DA receptors in two distinct groups of
striatal MSNs. According to this model, D1 receptor (D1-R)-
expressing MSNs of the direct pathway project to the substantia
nigra pars reticulata while D2 receptor (D2-R)-expressing MSNs of
the indirect pathway project to the medial globus pallidus [33].
Thus, we investigated whether the blockade of DAT by cocaine
in conjunction to A2A-R antagonism could affect glutamatergic
synaptic transmission in the entire MSN population or in a single
subset of neurons. Striatal MSNs obtained from mice expressing
BAC-EGFP under the control of D1-R promoter (D1-EGFP) or
D2-R promoter (D2-EGFP) were visualized with an infrared and
fluorescence-equipped microscope. Only neurons that displayed
a marked fluorescence were approached for patch-clamp record-
ings and underwent subsequent standard electrophysiological
characterization. We bath applied 10 mM cocaine plus 1 mM
ZM, in the continuous presence of 10 mM BMI, after recording
a stable EPSC baseline both in D1-EGFP- and in D2-EGFP-
MSNs. In these conditions the EPSC amplitude was reduced by
39.966.6% in D1-EGFP-MSNs (n=5) and by 34.566.8% in D2-
EGFP-MSNs (n=6), (Figure 2A,B).
To verify that the observed pharmacological effect induced by
cocaine and A2A-R antagonists was expressed in all MSNs, in
a subset of experiments, we combined electrophysiological
recordings and immunohistochemical identification of the neu-
rons. Thus, we patch-clamped MSNs using a biocytin-containing
pipette in order to allow subsequent immunohistochemical
identification of substance P-positive or A2A-positive MSNs,
(Figure 2E). As shown in figure 2C and 2D, the concomitant
application of 10 mM cocaine plus 1 mM ZM reduced the EPSC
amplitude in SP-positive and A2A-positive MSNs by 32.066.9%
(n=6) and 34.867.2% (n=6) respectively, providing an addition-
al confirmation that the reduction of excitatory synaptic response
exerted by cocaine in the presence of A2A-R antagonists is not
segregated in a subpopulation of MSNs (Figure 2E).
Cocaine and A2A Antagonists in the Striatum
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Reduce the Frequency of Glutamate Spontaneous
Release in Striatal MSNs by a CB1 Receptor-mediated
Action
We investigated the possible role of the combined activation of
D2-Rs and the inhibition of A2A-Rs by measuring the
spontaneous synaptic activity of excitatory inputs to striatal
MSNs. We stimulated D2-Rs, either by applying cocaine, that
enhances endogenous DA levels, or by applying the selective D2-
R agonist quinpirole. SEPSCs were recorded in the continuous
presence of 10 mM BMI to exclude GABAergic inhibitory
components of synaptic activity. In these conditions (pre-drug),
Figure 1. Effects of combined administration of cocaine and A2A-R antagonists on evoked EPSPs and EPSCs in striatal MSNs. (A)
Graph of the time-course of EPSP amplitude recorded in the presence of cocaine (10 mM) or ZM241385 (ZM, 1 mM) given in isolation and cocaine plus
ZM bath applied together with or without L-sulpiride (L-sulp, 5 mM), (cocaine plus ZM, vs cocaine F(9,72)=14.8, P,0.001; cocaine plus ZM plus L-sulp,
vs cocaine plu ZM F(9,72)=6.6, P,0.001). Example of superimposed EPSP pairs (top traces) before and 30 min after the application of ZM, cocaine, or
cocaine plus ZM. (B) Time-course of the EPSC amplitude in the presence of cocaine or ZM in isolation and cocaine plus ZM applied with or without
AM251 (AM, 3 mM), (cocaine plus ZM, vs cocaine F(9,72)=16.1, P,0.001; cocaine plus ZM plus AM, vs cocaine plus ZM, F(9,90)=10.9, P,0.001). Example
of EPSC superimposed pairs (top traces) before and 30 min after the application of ZM, cocaine, or cocaine plus ZM. (C) Dose-response curves of the
reduction of the EPSP amplitudes induced by cocaine in control conditions and in the presence of either ZM, ZM plus AM or ZM plus L-sulp (5 mM),
(cocaine plus ZM vs L-sulp plus cocaine plus ZM, F(4,24)=7.3, P,0.001; cocaine plus ZM plus AM vs cocaine plus ZM, F(4,36)=3.0, P,0.05). (D) Time-
course showing the averaged EPSC amplitudes in the presence of 10 mM CSC, and after the subsequent application of CSC plus 10 mM cocaine. Note
that the subsequent co-application of 5 mM L-sulp almost completely reverted the EPSC reduction achieved in the presence of CSC plus cocaine.
EPSCs superimposed traces (top) recorded from a single striatal MSN in control condition (pre-drug), in CSC alone, in CSC plus cocaine, and in CSC
plus cocaine plus L-sulp. (E) Time-course showing the lack of effect of cocaine plus CSC co-application on the EPSP amplitude measured in MSNs
recorded either with a BAPTA-containing internal solution and with the standard solution (BAPTA internal solution, vs standard solution, F(6,54)=26.1,
P,0.001). Example EPSC traces measured from a MSN recorded with a BAPTA-containing electrode in control condition and after the co-application
of 10 mM cocaine plus 10 mM CSC. (F) Histogram showing the increased EPSC ratios (EPSC2/EPSC1) in the presence of cocaine plus ZM or cocaine plus
CSC in respect to pre-drug condition (cocaine plus ZM vs pre-drug, t(2)=4.3, P,0.05; cocaine plus CSC vs pre-drug, t(2)=6.4, P,0.05). *P,0.05;
***P,0.001.
doi:10.1371/journal.pone.0038312.g001
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in the presence of cocaine (10 mM, n=4), D2-R agonist
quinpirole (10 mM, n=6), or A2A-R inhibitor ZM241385
(1 mM, n=7). These drugs did not affect per se the spontaneous
release of excitatory neurotransmitter, in fact, neither the
amplitude nor the frequency of sEPSCs were different from that
measured in pre-drug conditions (P.0.05, Figure 3B). On the
contrary, while the combined application of cocaine plus ZM or
quinpirole plus ZM did not affect the sEPSC amplitude, the
frequency was significantly affected (Figure 3A,B). In fact, the
sEPSC frequency in the presence of cocaine plus ZM was
reduced by 28.6619% (n=6, P,0.05) and in the presence of
quinpirole plus ZM by 27.065.6% (n=8, P,0.01) in respect to
the relative pre-drug condition (Figure 3A,B). Furthermore, we
recorded spontaneous EPSCs in the continuous presence of BMI
plus 1 mM TTX in order to measure miniature EPSCs
(mEPSCs), representing action potential-independent spontane-
ous release of neurotransmitter. Also in this case, while mEPCSs
amplitude was not affected either in the presence of 10 mM
cocaine plus 1 mMZ M( P .0.05) or in the presence of 10 mM
quinpirole plus 1 mMZ M( P .0.05), its frequency was reduced
by 38.866.5% (n=5, P,0.05) in the presence of cocaine plus
ZM and by 25.567.4% (n=5, P,0.05) in the presence of
quinpirole plus ZM, relatively to the respective pre-drug
condition (Figure 3A,B).
As observed for the modulation of the evoked synaptic
transmission, when the experiment was performed in the presence
of the CB1-R antagonist AM251 (3 mM), the reduction of the
frequency of spontaneous EPSC in the presence of cocaine or
quinpirole, co-applied with the A2A-R antagonist ZM, did not
occur (cocaine plus ZM plus AM vs AM, n=5, P.0.05; quinpirole
plus ZM plus AM vs AM, n=5, P.0.05, Figure 3C,D).
Cocaine and A2A Receptor-mediated Regulation of Firing
Activity in Striatal Cholinergic Interneurons
We recently reported that choline acetyl transferase (ChAT)-
positive striatal large aspiny (LA) interneurons co-express D2- and
A2A-Rs and are deeply involved in the D2/A2A-R-dependent
modulation of striatal excitatory synaptic transmission since D2-R
agonist and A2A-R antagonist reduced the firing rate of these
interneurons that potentially control the synaptic transmission of
the entire population of striatal MSNs [24]. Cocaine administra-
tion might therefore also exert a similar action on D2-Rs expressed
on LA interneurons by its direct effect on the DAT, thus increasing
intrastriatal DA levels.
LA interneurons were patch-clamped in current-clamp mode
and, as shown in figure 4A,B,C,E, neither a low dose of cocaine
(0.1 mM, n=5) nor 10 mM of the caffeine-derivative CSC (n=4)
affected either the resting membrane potential or the firing rate of
these neurons when applied in isolation. However, cocaine
reduced the firing frequency of these neurons in a dose-dependent
manner at higher concentrations (n=5 for each dose, Figure 4E).
The co-application of cocaine plus 10 mM CSC significantly
enhanced cocaine effect of the firing frequency (P,0.001). In fact,
in the presence of CSC, even 0.1 mM cocaine was able to reduce
the neuronal firing frequency of LA interneurons by 59.767.2%
(Figure 4D,E,F).
The block of DA transporter and the subsequent increase of
endogenous DA levels together with A2A adenosine signaling
might thus regulate the firing discharge of cholinergic interneurons
toward MSNs and subsequently regulate striatal excitatory
synaptic transmission by an eCB-mediated mechanism [24].
Activation of M1-Like Muscarinic Receptor is Required for
the Reduction of Excitatory Synaptic Transmission
Induced by Cocaine and A2A-R Antagonist
In physiological conditions D2-R agonists, in combination with
A2A-Rs antagonists, were able to reduce striatal cholinergic
transmission and, in turn to inhibit glutamate release toward
MSNs acting on postsynaptic M1-like muscarinic receptors [24].
In order to verify the involvement of M1-like receptors in the
cocaine-and A2A-R-mediated reduction of striatal glutamatergic
transmission we recorded evoked and spontaneous MSNs EPSCs
in the continuous presence of 2 mM pirenzepine applied for the
whole duration of the experiments. After 15 minutes in
pirenzepine (pre-drug), bath application of 10 mM cocaine plus
1 mM ZM for 25 minutes did not produce any change of the
evoked EPSCs (n=6; P.0.05; Figure 5A,B). Spontaneous EPSCs
were also recorded after 15 minutes of pirenzepine (pre-drug) and
then after 20–25 minutes of cocaine and ZM application. In these
conditions the sEPSCs were also not affected, in fact, neither the
sEPSC amplitude nor the frequency were altered by cocaine plus
ZM application in respect to pre-drug conditions (n=8; P.0.05;
Figure 5C). Thus, blockade of M1-like receptors occluded cocaine
and A2A-R mediated reduction of glutamatergic transmission
(P,0.01; Figure 5B,C).
Motor Stimulation Induced by Cocaine and A2AR
Antagonists Co-administration is Influenced by CB1 and
D2 Receptors
To unveil if reduced glutamatergic synaptic excitatory trans-
mission in both D2- and D1-R-expressing MSNs, produced by
concomitant exposure to cocaine and A2A-Rs antagonists, might
have direct behavioral consequences, we analyzed motor effects
produced by the co-administration of these drugs.
First, we evaluated motor response of mice to different doses of
cocaine(1.25,5or10 mg/kg)inordertofindtheconcentrationthat
was ineffective to stimulate locomotor activity (Figure 6A). Among
the doses tested, 1.25 mg/kg did not show significant effects on
motor stimulation, compared to vehicle treatment (P.0.05).
Therefore, 1.25 mg/kg cocaine was chosen as the sub-effective
dose for the co-administration experiments described below.
Secondary, we analyzed the effect of concomitant administra-
tion of cocaine and CSC, a selective A2A-R antagonist (Figure 6B).
Before co-administration, we also tested the sub-effective dose of
CSC, that resulted in 2.5 mg/kg (data not shown). We found that
co-administration of ineffective doses of cocaine and CSC was able
to induce a significant increase of motor response, compared with
injections of vehicle, cocaine or CSC alone (P,0.01, per each
treatment; post-hoc analysis). Interestingly, treatment with the
selective CB1-R antagonist AM251 (5 mg/kg) abolished the motor
stimulation induced by co-administration of cocaine and CSC
(P,0.01, post-hoc analysis). To confirm this observation, we tested
Figure 2. Cocaine and A2A-R pharmacological modulation affects excitatory synaptic transmission in both D2-and D1-receptor
expressing striatal MSNs. Time-course plots of the EPSC amplitude and EPSC superimposed pairs recorded in the presence of cocaine plus ZM in
D1-EGFP MSNs (A) and in D2-EGFP MSNs (B). Effect of cocaine plus ZM co-application on the time-course of EPSC amplitude recorded in substance P
(SP) positive (C) and A2A positive (D) MSNs. (E) Representative images from confocal laser scanning microscopy of the immunofluorescence from
a biocytin and SP containing MSN (top) and from a biocytin and A2A-R containing MSN (bottom) and the relative merged images.
doi:10.1371/journal.pone.0038312.g002
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(Figure 6C). A pilot test indicated as 5 mg/kg the sub-effective
dose of ZM241385 for co-administration experiment (data not
shown). Similarly to CSC, mice co-administered with ineffective
doses of cocaine and ZM241385 showed a significant increase of
locomotion, compared to mice treated with vehicle, cocaine or
ZM241385 alone (P,0.01, per each treatment). Also in this case,
motor activity induced by co-administration was suppressed when
mice received also AM251 (P,0.01).
Electrophysiological analysis indicated that, besides CB1-R
activation, stimulation of D2-Rs plays as well a main role in
modulating the striatal excitatory synaptic transmission. There-
fore, we investigated the effect of the D2-R antagonist L-sulpiride
on motor activity induced by cocaine-CSC co-administration
(Figure 6D). Statistical analysis showed that treatment with
15 mg/kg L-sulpiride was able to inhibit the motor hyperactivity
evoked by concomitant injection of cocaine and CSC (P,0.01),
thus confirming electrophysiological findings.
Discussion
In this work we examined the effects of cocaine on striatal
excitatory synaptic transmission and motor activity when admin-
istered in combination with A2A adenosine receptor antagonists.
Given the physiological and social impact of assumption of cocaine
in the presence of other psychotropic drugs, such as caffeine-like
compounds, that specifically target endogenous adenosinergic
signaling, to block A2A-Rs we used the caffeine-derivative 8-(3-
chlorostyryl)-caffeine and ZM241385. In this study we provided
for the first time electrophysiological evidence of a significant
inhibition of striatal excitatory synaptic transmission exerted by
cocaine in combination with A2A-R antagonists. In a previous our
publication [24], we have already reported that the concomitant
activation of D2 receptors by ‘‘exogenous’’ agonists and the
blockade of A2A receptors reduce striatal glutamatergic trans-
mission both in physiological condition and in experimental
models of Parkinson’s disease. Here, however, we describe for the
first time the striatal electrophysiological effects produced by the
Figure 3. The co-application of cocaine or quinpirole together with A2A-R antagonist similarly reduce spontaneous EPSC by a CB1
receptor-dependent action. (A) Representative traces of sEPSCs and mEPSCs recorded in control conditions (pre-drug) and in the presence of
10 mM cocaine plus 1 mMZ Mo r1 0mM quinpirole plus 1 mM ZM. (B) Histogram of averaged amplitude and frequency of sEPSCs in the presence of
cocaine, quinpirole and ZM applied in isolation (top). Averaged amplitude and frequency of sEPSCs and mEPSCs measured in the presence of cocaine
or quinpirole co-applied with ZM (bottom), (sEPSC frequency: cocaine plus ZM, vs pre-drug, t(5)=3.7, P,0.05; cocaine plus quinpirole, vs pre-drug,
t(7)=4.6, P,0.01. mEPSC frequency: cocaine plus ZM, vs pre-drug, t(4)=3.2, P,0.05; cocaine plus quinpirole, vs pre-drug, t(4)=2.9, P,0.01). (C) Traces
of sEPSCc in control conditions (pre-drug) and after the co-application of cocaine or quinpirole plus ZM and the CB1-R antagonist AM251. (D)
Averaged sEPSC amplitude and frequency in the presence of AM251, cocaine plus ZM plus AM or quinpirole plus ZM plus AM. *P,0.05; **P,0.01.
doi:10.1371/journal.pone.0038312.g003
Cocaine and A2A Antagonists in the Striatum
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interaction with A2A receptors. Moreover, we have also addressed
the possible behavioural implication of this interaction on motor
activity. We demonstrated that the effect of cocaine in this
interaction is produced by the activation of D2 DA-R, since L-
sulpiride prevents the reduction of the excitatory postsynaptic
response in MSNs. The importance of DA signaling, involving the
activation of D2-Rs, is strengthened by the analysis of MSNs
spontaneous excitatory events. In fact, we found that the
frequency, but not the amplitude, of spontaneous EPSCs was
only reduced by the combined superfusion of cocaine or the D2-R
agonist quinpirole plus an A2A-R antagonist. The effect on the
frequency but not on the amplitude, suggests the involvement of
a presynaptic mechanism activated by these drugs. Therefore,
increased striatal DA level, achieved by cocaine-induce DAT
blockade, appears to be a pivotal signal required for the reduction
of cocaine and A2A-R-mediated glutamatergic neurotransmission.
Cocaine and A2A-R inhibition of synaptic response also
required postsynaptic intracellular calcium changes and the
activation of CB1-Rs since intracellular BAPTA or bath applica-
tion of a CB1-R antagonist significantly opposed this inhibitory
response. Thus, according to previous published works
[25,27,32,34,35], eCBs released by postsynaptic MSNs by
a calcium-mediated mechanism, reduce glutamatergic striatal
neurotransmission by stimulating presynaptic CB1-Rs. Our
analysis of the changes of paired-pulse stimulated EPSCs revealed
Figure 4. Cocaine and 8-(3-Chlorostyryl)-caffeine co-application reduce the firing discharge rate of striatal cholinergic
interneurons. (A) Representative confocal laser scanning microscopy images of striatal cholinergic interneurons filled with biocytin during
electrophysiological recordings. Double immunofluorescence detection of biocytin and anti-choline acetyl transferase (ChAT). Biocytin is visualized in
green-cy2 fluorescence (a), ChAT in red-cy3 fluorescence (b). Left panel is the merged image (c) Scale bar: 50 mm. (B) Representative time-course of
the firing rate and example of trace recordings from cholinergic interneurons in control conditions and in the presence of 0.1 mM cocaine (B), 10 mM
CSC (C) or cocaine plus CSC (D), respectively. Plotted mean frequency of the firing activity is calculated in time windows of 5 seconds. (E) Dose-
response curves of spike frequency from cholinergic interneurons measured in the presence of cocaine or cocaine plus CSC (cocaine, vs cocaine plus
CSC, F(3,28)=6.5, P,0.01). (F) Histogram of averaged firing frequency of cholinergic interneurons recorded in the presence of cocaine, CSC and
cocaine plus CSC, cocaine vs cocaine plus CSC, Bonferroni’s post-hoc test, ***P,0.001.
doi:10.1371/journal.pone.0038312.g004
Figure 5. M1-like muscarinic receptor blockade prevents the reduction of excitatory synaptic transmission induced by cocaine and
A2A-R antagonist. (A) Time-course showing evoked EPSC amplitude recorded from striatal MSNs in the continuous presence of the M1-like
receptor blocker pirenzepine (2 mM). 10 mM cocaine plus 1 mM ZM are bath applied during pirenzepine perfusion. Representative traces of EPSC
acquired 2 minutes before (left) and 20 minutes after (right) the co-application of cocaine plus ZM, bath applied 15 minutes after the onset of
pirenzepine. (B) Histogram showing the effect on the EPSC amplitude of 25 minutes co-application of cocaine plus ZM in the presence of pirenzepine
compared to the effect in the standard solution (EPSC amplitude t(10)=6.9, P,0.001). (C) Histograms showing the effect of co-application of cocaine
plus ZM on spontaneous EPSC amplitude (left) and frequency (right), in the presence of pirenzepine or in comparison to the effect in the standard
solution (sEPSC frequency t(12)=3.9, P,0.01). **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0038312.g005
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PPR in MSNs, also supporting the involvement of a presynaptic
mechanism of action. Furthermore, the CB1-R antagonist AM251
prevented the reduction of spontaneous EPCS frequency of MSNs
in the presence of either cocaine or the D2-R agonist quinpirole,
when applied in combination with a A2A-R antagonist. Consid-
ering the abundant presence of striatal CB1-Rs on presynaptic
glutamatergic terminals, we provide additional evidence of
a presynaptic mechanism involvement. These lines of evidence
strongly support a D2-and A2A-R mediated calcium-dependent
release of eCBs from postsynaptic MSNs, triggered by the
combined application of cocaine and A2A-R antagonists.
Interestingly, as revealed by immunofluorescence analysis of
patch-clamped MSNs from BAC-EGFP mice and from MSNs
expressing substance P or A2A-Rs we found that the combined
effect of cocaine and A2A-R antagonism was not segregated to
specific neuronal striatal subpopulations. In fact, we report that in
the presence of cocaine plus the A2A-R antagonist ZM, the
inhibition of the EPSC amplitude was similar in D1-EGFP- and
SP-expressing neurons as well as in D2-EGFP and A2A-R-
expressing cells, identified as D1-R or D2-R expressing MSNs,
respectively. According to these data it has been shown that in
most of the recordings from striatal MSNs, activation of D2-Rs
inhibits striatal glutamate release by a retrograde eCB signaling
[36] and that cocaine can increase the level of the eCB
anandamide in the striatum through the stimulation of DA D2-
like receptors [37].
These findings are in line with results from our previous work in
which we have shown that LA interneurons of the intrastriatal
network may exert a major modulatory role of the synaptic
excitatory response of both D2-R- and D1-R-expressing MSNs.
This action was achieved by regulating intracellular calcium via
M1 muscarinic receptors, and we showed that cholinergic firing
tone was reduced by a the D2-R agonist quinpirole and a A2A-R
antagonist [24,38]. In the present work, we extended these
findings providing evidence that cocaine can affect the firing
frequency of LA interneurons, in a dose-dependent way, similarly
to the action of D2-R agonist [24]. These findings are supported
by previous studies in which increased DA release results in
decreased acetylcholine release in dorsal striatum [24,39,40], by
the presence of DA D2-Rs [41] and adenosine receptor mRNAs,
including A2A-R mRNA in striatal LA interneuron, suggesting the
possibility that these receptors, together with D2-R, might
modulate acetylcholine release [42].
Furthermore, we found that a sub-threshold dose of cocaine that
does not affect the firing frequency of LA neurons, is sufficient to
produce a robust effect in reducing the firing frequency when
applied in combination with the caffeine derivative CSC that
specifically blocks A2A-Rs. These findings support the important
role of intrastriatal cholinergic in the regulation of motor
functions.
We can hypothesize that the synergistic action of cocaine and
A2A-R antagonists in inhibiting the firing rate of cholinergic
interneurons would result in the reduction of endogenous
acetylcholine release and the consequent reduced activation of
M1 muscarinic receptors on MSNs. The established effect of M1
receptor inhibition would be the opening of L-type Ca
2+ channels
[38]. This latter event might trigger postsynaptic effects on MSNs
leading to eCBs release and reduction of glutamatergic trans-
mission by the activation of presynaptic CB1 receptors (Figure 7).
Figure 6. Influence of CB1 and D2 receptors on motor activity
induced by co-administration of cocaine and A2A-R antago-
nists. (A) Effect of 1.25, 5 and 10 mg/kg cocaine on locomotor activity
of C57BL/6 mice (n=12 vehicle, n=6 per each dose of cocaine). (B)
Locomotor activity induced by administration of vehicle (n=6),
1.25 mg/kg cocaine (n=6), 2.5 mg/kg CSC (n=6), cocaine-CSC co-
administration (n=6), cocaine-CSC plus 5 mg/kg AM251 injection
(n=12). (C) Locomotor activity induced by administration of vehicle
(n=9), 1.25 mg/kg cocaine (n=6), 5 mg/kg ZM241385 (n=10), cocaine-
ZM241385 co-administration (n=6), cocaine-ZM241385 plus 5 mg/kg
AM251 injection (n=6). (D) Locomotor activity induced by vehicle
(n=6), cocaine-CSC co-administration (n=7) and cocaine-CSC plus
15 mg/kg L-sulpiride injection (n=6). Locomotor activity is shown as
both time course (left panels) and total distance travelled (right panels)
over 45-min test sessions. All values are expressed as mean 6 SEM.
**P,0.01, compared to vehicle-treated mice; uuP,0.01, compared to
mice co-administered with cocaine and A2A-R antagonists (CSC or
ZM241385), (Fisher’s post-hoc analyses).
doi:10.1371/journal.pone.0038312.g006
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receptor inhibitor, the electrophysiological effects of cocaine plus
A2A-R antagonists modulation on glutamatergic transmission
were fully occluded. LA interneurons can also modulate the
activity of MSNs by decreasing glutamate release via stimulation
of presynaptic M2 receptors located on MSN glutamatergic
afferents [43]. Presynaptic M2 receptors might therefore be
involved in the fine regulation of MNS excitability together with
eCBs after the concomitant application of cocaine and A2A-R
antagonists.
Electrophysiological effects of combined exposure to cocaine
with either CSC or ZM reflected in changes of the motor function.
In fact, while cocaine administration per se increased spontaneous
motor activity, as previously reported [4] in this work we
characterized for the first time the additive effect of a sub-
threshold doses of co-administered cocaine and A2A-R antagonists
on motor activity. While previous findings have shown that the
pharmacological inhibition of DA activity blocked cocaine-
activated spontaneous behavior [44], our data clearly demonstrate
that cocaine- and A2A-R-activated effects on mice locomotion is
specifically mediated by DA D2-Rs since L-sulpiride fully
prevented the motor effect observed in the presence of cocaine
and CSC.
It has been already suggested that eCBs signaling mediates
psychomotor activation by A2A-R antagonists [45]. The authors
claimed that their finding was consistent with a model in which
eCBs-mediated inhibition of the indirect pathway increases
movement. This interpretation is in line with the classical theory
of the segregation within the basal ganglia postulating that
increased direct-pathway activity facilitates movement, while
increased indirect-pathway activity inhibits movement [46,47].
Our findings show that cocaine (via D2-R) and A2A-R antagonists
control the striatal cholinergic system and subsequently regulate
eCBs production in MSNs of both direct- and indirect pathway,
opening a novel and different scenario. This view, also supported
by our recent electrophysiological findings in experimental models
of Parkinson’s disease [24,48], suggests that plasticity of glutama-
tergic transmission, rather than being expressed in distinct and
opposite manner in the two pathways, affects the two striatal
population subtypes leading to motor activation. In line with
a previous hypothesis [38], the cholinergic interneurons seem to
play a central role in orchestrating these physiological and
pharmacological responses. However, the behavioural effects
observed after the co-administration of cocaine and/or A2A
antagonists might be under the control of different brain regions,
thus alternative explanations should be taken into account. CB1-R
stimulation in the ventral tegmental area, in fact, can increase the
firing rate of DA neurons [49]. Furthermore, CB1-Rs activation
might also contribute to increase striatal DA levels following
systemic cocaine administration [50]. Therefore, the role of CB1-
R activation upstream of the striatum on cocaine-evoked DA
release, presumably contributes to the locomotor effects of cocaine
that are inhibited by CB1-R antagonism.
Materials and Methods
Electrophysiology
All the experiments were conducted in conformity with the
European Communities Council Directive of November 1986
(86/609/ECC) in accordance with a protocol approved by the
Animal Care and Use Committee at the University of Perugia and
every effort was made to minimize animal suffering. Two to three
months-old male Wistar rats (Harlan) and 5–6 weeks old male
C57Bl/6J mice carrying BAC that express enhanced green
fluorescent protein (BAC-EGFP) under the control of D1-R
promoter (drd1a-EGFP) or D2-R promoter (drd2-EGFP) were used
for electrophysiological experiments. BAC-EGFP mice were
originally generated by the GENSAT (Gene Expression Nervous
System Atlas) program at the Rockefeller University [51].
Coronal slices including the cortex and the striatum were cut
from rats (thickness, 270 mm) or from BAC-EGFP mice (thickness,
220–240 mm) brain using a vibratome. A single slice was
transferred to a recording chamber and submerged in a continu-
ously flowing Kreb’s solution (34uC; 2.5–3 ml/min) bubbled with
a 95% O2–5% CO2 gas mixture. The composition of the Kreb’s
solution was (in mM) 126 NaCl, 2.5 KCl, 1.2 MgCl2,
1.2 NaH2PO4, 2.4 CaCl2, 10 glucose, and 25 NaHCO3. Drugs
were bath-applied by switching the solution to one containing
known concentrations of drugs. Powders were dissolved in water
or DMSO and aliquoted. Drugs were applied by dissolving them
to the desired final concentration in the external Kreb’s solution
[24,52]. For intracellular recordings, electrodes were pulled from
borosilicate glass pipettes, backfilled with 2 M KCl (30–60 MV).
Only neurons electrophysiologically identified as spiny neurons
were considered for experiments with sharp microelectrodes. An
Axoclamp 2B amplifier (Molecular Devices) was connected in
parallel to an oscilloscope to monitor the signal in ‘‘bridge’’ mode
and to a PC for acquisition of the traces using pClamp 10 software
(Molecular Devices) [29]. MSNs from slices of mice expressing
BAC-EGFP under the control of D1-R promoter (D1-EGFP) or
D2-R promoter (D2-EGFP) were visualized with an infrared- and
Figure 7. Model of intrastriatal network during cocaine and
A2A-R antagonists exposure. The administration of cocaine
enhances intrastriatal dopamine (DA) levels by blocking the DA
transporter (DAT) expressed on DA terminals. The simultaneous effect
of the stimulation of D2-Rs by DA and the blockade of A2A-Rs by CSC or
ZM, on cholinergic interneurons might decrease the release of
acetylcholine at the synaptic sites of D2-and D1-R expressing MSNs.
The subsequent reduced stimulation of M1-like cholinergic receptors
and opening of high-voltage activated Ca
2+ channels (HVA) would
trigger Ca
2+-mediated release of endocannabinoids. This retrograde
messenger might ultimately inhibit excitatory striatal excitatory trans-
mission by the stimulation of CB1 receptors located on presynaptic
glutamatergic sites.
doi:10.1371/journal.pone.0038312.g007
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recordings, signals were amplified with a Multiclamp 700B
amplifier (Molecular Devices), recorded and stored on PC using
pClamp 10. Whole-cell access resistance was 5–30 MV, holding
current ranging between 80 to 250 pA.
Whole-cell voltage-clamp recordings (holding potential,
280 mV) were performed with borosilicate pipettes (4–7 MV)
filled with a standard internal solution containing (in mM):
145 K
+-gluconate, 0.1 CaCl2, 2 MgCl2, 0.1 EGTA, 10 HEPES,
0.3 Na-GTP and 2 Mg-ATP, adjusted to pH 7.3 with KOH.
When a BAPTA-containing internal solution was used,
20 mM BAPTA was added to the standard solution and K
+-
gluconate was lowered to 125 mM. Some electrodes were filled
with the standard solution plus biocytin.
A bipolar electrode, connected to a stimulation unit (Grass
Telefactor), was located in the white matter between cortex and
striatum to stimulate glutamatergic fibers (0.1 Hz) and evoke
excitatory postsynaptic potentials (EPSPs) and currents (EPSCs).
Current traces for spontaneous EPSCs were recorded in the
continuous presence of 10 mM BMI (sEPSCs) or BMI plus 1 mM
tetrodotoxin to isolate miniature EPSCs (mEPSCs). Five minute
episodes were acquired during the pre-drug condition and 20
minutes after of drug application. Cholinergic large aspiny (LA)
interneurons, were localized under IR-DIC visualization by their
large soma and subsequently identified by their electrophysiolog-
ical properties. They were recorded in whole-cell current-clamp
mode using an internal solution containing (in mM): 120 K
+-
gluconate, 0.1 CaCl2, 2 MgCl2, 1 EGTA, 10 HEPES, 0.3 Na-
GTP and 2 Mg-ATP, adjusted to pH 7.3 with KOH. These cells
presented a pronounced h-current (Ih) and a typical sag potential
in response to hyperpolarizing steps of current [24,53–55]. The
majority of LA interneurons were firing spontaneously [54]. Cells
that were not spontaneously active were injected with 10–50 pA of
positive current for reaching the threshold of action potential.
Quantitative data are expressed as a percentage of EPSP and
EPSC amplitudes or firing frequency with respect to the relative
control values, the latter representing the mean of responses
recorded during a stable period (10–15 min). The spontaneous
events were detected using Clampfit 10 (Molecular Devices) and
confirmed visually for accuracy. Amplitude and frequency were
measured in epochs of 5 minutes.
Tissue Processing and Double Immunofluorescence
Brain slices that were used for electrophysiological recordings
were processed to verify the presence of cells filled with biocytin.
Thus, they where post-fixed overnight at +4uC with 4% para-
formaldehyde in saline solution and then cryo-protected in
phosphate buffer (PB 0.1 M) with sodium azide 0.02% for 48
hours at 4uC. Sections were incubated with streptavidin-Cy3
diluted 1:600 in PB-TX-100 0.3% for 2 hours at room
temperature and quickly observed, under an epi-illumination
uorescence microscope (Zeiss Axioskop 2).
A first set of brain slices was preincubated with a primary
antibody guinea pig anti-SP or rabbit polyclonal anti-A2A to label
MSNs of the ‘‘direct’’ or ‘‘indirect’’ basal ganglia pathway,
respectively [23,56–59]. The primary antisera were used at
a concentration of 1:400 for SP and 1:250 for A2A in 0.1 M PB
containing Triton X-100, 0.3% and sodium azide, 0.02% for 24
hours at room temperature and 48 hours at 4uC. Sections were
then rinsed three times for 15 minutes at room temperature, and
subsequently incubated with Alexa fluor 488 goat anti-guina pig or
Alexa fluor 647 chicken anti-rabbit secondary antibody for 2 hours
at room temperature. All secondary antibodies were used at 1:200
concentration. Tissue was mounted on gelatin-coated slides,
coverslipped with GEL-MOUNT and examined under an epi-
illumination uorescence microscope (Zeiss Axioskop 2), and
a CLSM (Zeiss LSM 700) was used to acquire all the images.
In order to label biocytin-filled cholinergic interneurons,
a second set of slices, used for electrophysiological recordings,
was also processed to detect the presence of choline acetyl
transferase. Slices were incubated with a primary antibody rabbit
anti-choline acetyl transferase (ChAT; Immunological Science,
Rome Italy) to label the cholinergic interneurons. The primary
antisera were used at a 1:400 concentration in 0.1 M PB
containing Triton X-100, 0.3% and sodium azide, 0.02% for
24 h a room temperature and 48 h at 4uC. Sections were then
rinsed three times for 15 min at room temperature, and sub-
sequently incubated with a goat anti-rabbit Cy2-conjugated
secondary antibody (Jackson Immunoresearch, West Grove, PA,
USA) for 2 hours at room temperature. Tissue was mounted on
gelatin-coated slides, coverslipped with GEL-MOUNT and
examined under an epi-illumination fluorescence microscope
(Zeiss Axioskop 2), and a CLSM (Zeiss LSM 510) was used to
acquire all the images.
Motor Responses Induced by Drugs
Locomotor activity was analyzed as previously described [60].
To investigate the effect of CB1-R-dependent stimulation on
locomotor activity induced by cocaine and the A2A-R antagonist,
CSC, C57BL/6 mice were divided in 5 groups, each of them
receiving: (1) vehicle, (2) cocaine alone (1.25 mg/kg), (3) CSC
alone (2.5 mg/kg), (4) cocaine plus CSC, (5) cocaine plus CSC plus
AM 251 (5 mg/kg). Similarly, to investigate the effect of CB1-R
stimulation on locomotor activity induced by cocaine and the
A2A-R antagonist, ZM241385, mice were divided in 5 groups,
each of them receiving: (1) vehicle, (2) cocaine alone (1.25 mg/kg),
(3) ZM241385 alone (5 mg/kg), (4) cocaine plus ZM241385, (5)
cocaine plus ZM241385 plus AM 251 (5 mg/kg). Finally, to study
the effect of D2-R stimulation on locomotor activity induced by
cocaine and A2A-R antagonist CSC, mice were divided in 3
groups, each of them receiving: (1) vehicle, (2) cocaine plus CSC,
(3) cocaine plus CSC plus L-sulpiride (15 mg/kg). Drugs or vehicle
were injected intraperitoneally.
Mice were first habituated to the experimental cage for 60 min
and then injected with the drugs reported above. CSC, AM251,
ZM241385 and L-sulpiride were dissolved in vehicle (50%
polyethylene glycol, PEG and 50% saline) whereas cocaine was
prepared in saline. Recording of locomotor activity started 15 min
after last injection and was detected over test session 45 min by
a computerized video tracking system (Videotrack, Viewpoint S.A.
Champagne au Mont d’Or, France). Total distance traveled was
analyzed by ANOVA, followed by Fisher’s post-hoc analysis, when
required.
Statistical Analysis
Off-line analysis was performed using Clampfit 10 (Molecular
Devices) and GraphPad Prism 5.0 (GraphPad Software Inc.)
software. Two-way ANOVA or Student’s t-test were used. Values
are mean 6 SE; ‘‘n’’ is the number of recorded neurons. The
significance level was established at P,0.05 (*), P,0.01 (**) and
P,0.001 (***).
Chemicals
AM251 (AM), pirenzepine dihydrochloride, (-)-quinpirole
hydrocholoride, (L)-sulpiride, tetrodotoxin citrate (TTX),
ZM241385 (ZM) were from Tocris-Cookson; (-)-bicuculline
methiodide (BMI), cocaine, 8-(3-Chlorostyryl)-caffeine (CSC),
streptavidin-Cy3 were from Sigma-Aldrich. Anti-SP was from
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647 were from Invitrogen, Molecular probes.
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